AFP and hepatocellular carcinoma: Along the same line, additional studies from China have suggested that several diagnostic models based on methylation markers and mutations can exhibit high rates of sensitivity (60–94%) and specificity (91–98.5%) for HCC diagnosis [28,29,30,31,32], whereas the combined use of traditional markers including AFP appears to potentially increase the diagnostic performance of such tests [28,30].